Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
sPIF in Patients With High Panel Reactive Antibodies
NCT03593421Phase 2Withdrawn
- Start
- Feb 2019
- Primary completion
- Dec 2020
- Modality
- Antisense DNA, Small Interfering RNA (siRNA), Peptides
01
Overview
A Phase 2 trial of synthetic preimplantation factor in panel reactive antibody (PRA). Planned start Feb 2019; status: withdrawn.
02
Drugs
synthetic preimplantation factor
03
Conditions
panel reactive antibody (PRA)
Beyond the preview
Go deeper on NCT03593421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03593421.